Profile: Mylan Pharmaceuticals Inc. manufactures prescription medicines specializing in producing & marketing generic pharmaceuticals. We deal with products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease & schizophrenia to sleep disorders. We supply over 140 generic products in approximately 360 product strengths, covering over 40 therapeutic categories. Our Bicalutamide tablet 50 mg is an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone releasing hormone analog for the treatment of stage D2 metastatic carcinoma of prostrate.

The company was founded in 1961, has revenues of USD 1-5 Million, has ~50 employees and is ISO 9000, CE certified. NYSE:MYL (SEC Filings)